<DOC>
	<DOCNO>NCT00247429</DOCNO>
	<brief_summary>In study assess primary objective effect venlafaxine retard treatment primary care attend elderly patient depressive syndrome . We also study secondarily effect anxiety , somatic painful symptom depression .</brief_summary>
	<brief_title>Study Evaluating Venlafaxine Extended Release Elderly Depressed Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>Patients older 60 year Depressive syndrome associate anxiety symptom , accord symptom intensity HAMD17Â³14 Participation study last 3 month start study Known hypersensibility venlafaxine Clinically significant abnormality accord venlafaxine labeling</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>depression</keyword>
	<keyword>anxiety</keyword>
	<keyword>elderly</keyword>
</DOC>